This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ono, N.
Right arrow Articles by Yanagi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ono, N.
Right arrow Articles by Yanagi, Y.

 Previous Article  |  Next Article 

Journal of Virology, May 2001, p. 4399-4401, Vol. 75, No. 9
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.9.4399-4401.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Measles Viruses on Throat Swabs from Measles Patients Use Signaling Lymphocytic Activation Molecule (CDw150) but Not CD46 as a Cellular Receptor

Nobuyuki Ono,1 Hironobu Tatsuo,1 Yasufumi Hidaka,2 Tomonobu Aoki,3 Hiroko Minagawa,1 and Yusuke Yanagi1,*

Department of Virology, Faculty of Medicine, Kyushu University, Fukuoka 812-8582,1 Department of Pediatrics, Kitakyushu Municipal Medical Center, Kitakyushu 802-0077,2 and Fukuoka City Children's Hospital and Medical Center for Infectious Disease, Fukuoka 810-0063,3 Japan

Received 7 December 2000/Accepted 29 January 2001


    ABSTRACT
Top
Abstract
Text
References

Both CD46 and signaling lymphocytic activation molecule (SLAM) have been shown to act as cellular receptors for measles virus (MV). The viruses on throat swabs from nine patients with measles in Japan were titrated on Vero cells stably expressing human SLAM. Samples from all but two patients produced numerous plaques on SLAM-expressing Vero cells, whereas none produced any plaques on Vero cells endogenously expressing CD46. The Edmonston strain of MV, which can use either CD46 or SLAM as a receptor, produced comparable titers on these two types of cells. The results strongly suggest that the viruses in the bodies of measles patients use SLAM but probably not CD46 as a cellular receptor.


    TEXT
Top
Abstract
Text
References

Measles virus (MV) is an enveloped negative-strand RNA virus of the Morbillivirus genus in the Paramyxoviridae family (4). Measles remains an important cause of childhood mortality, with approximately one million deaths per year worldwide (2), mainly due to secondary infections caused by MV-induced immunosuppression (4). Human CD46 has been shown to be a cellular receptor for vaccine strains of MV, such as the Edmonston strain (3, 10). However, wild-type MV strains that are commonly isolated in marmoset B-cell line B95a or human B-cell lines usually do not use CD46 as a receptor (5-7, 14, 15, 18), although a study has reported that MV strains isolated from and propagated only in human peripheral blood mononuclear cells (PBMCs) use CD46 as a receptor (9). We have recently demonstrated that signaling lymphocytic activation molecule (SLAM; also known as CDw150) is a cellular receptor for MV, including the Edmonston strain, B95a-isolated strains, and PBMC-isolated strains (20). Thus, some MV strains use SLAM but not CD46 as a receptor, and others, such as the Edmonston strain, use either SLAM or CD46. The type of MV strain obtained depends on the cell types used for virus isolation. In this study, we sought to quantitate the proportions of these two types of MV in measles patients.

Vero cells are susceptible to the Edmonston strain but not to B95a-isolated MV strains (6, 18). In order to titrate B95a-isolated MV strains on Vero cells, we transfected them with the expression plasmid encoding human SLAM (pCAG-hSLAM) (12) and the vector plasmid pCXN2 (11) containing the neomycin resistance (neo) gene; we selected stable clones in the presence of G418. We used the clone expressing the highest level of human SLAM (Vero/hSLAM) in the following experiments.

The expression profile of Vero/hSLAM cells stained with anti-human SLAM monoclonal antibody IPO-3 (Kamiya Biomedical) (17) is shown in Fig. 1A. Vero/hSLAM cells were infected with the B95a-isolated KA strain of MV (18-20) at a multiplicity of infection of 0.1. At 24 h after infection, they developed extensive syncytia (Fig. 1B), unlike the parental Vero cells (6, 18). Then, we used Vero and Vero/hSLAM cells for plaque titration of the KA strain. Vero/hSLAM cells developed clear plaques after infection with the KA strain, whereas Vero cells inoculated with the same amount of the virus did not show any plaques (Fig. 1C).


View larger version (79K):
[in this window]
[in a new window]
  		FIG. 1.   Characterization of Vero/hSLAM cells. (A) Vero/hSLAM cells were stained with IPO-3 (thick line) or a mouse immunoglobulin G1 (IgG1) control antibody (thin line), followed by staining with fluorescein isothiocyanate-labeled anti-mouse IgG. The stained cells were analyzed on a FACScan machine (Becton Dickinson). (B) Vero/hSLAM cells were either uninfected or infected with the KA strain of MV and observed under a microscope at 24 h after infection. (C) The diluted stock of the KA strain was titrated on Vero or Vero/hSLAM cells. At 3 days after infection, plates were stained with crystal violet and photographed.

We next compared MV titers on Vero/hSLAM cells with those on Vero cells. B95a cells and Chinese hamster ovary (CHO) cells stably expressing human SLAM (CHO/hSLAM) (20) or human CD46 (CHO/CD46) (19) were also used for the titration. Vero, Vero/hSLAM, CHO, CHO/CD46, and CHO/hSLAM cells (5 × 105 cells per well) were seeded in six-well plates on the day before infection and then inoculated with 0.5 ml of the Edmonston or KA strain of MV appropriately diluted in phosphate-buffered saline containing 5% fetal bovine serum. At 1 h after infection, the cells were overlaid with 3 ml of medium containing 0.5% agarose and then incubated at 37°C in a 5% CO2 incubator. At 3 days after infection, the cells were fixed with formaldehyde and stained with crystal violet. After washing, the numbers of plaques were counted, and PFU per milliliter were calculated. B95a cells were plated in 96-well plates and then infected with the Edmonston or KA strain, and 50% tissue culture infective doses (TCID50) were determined at 3 days after infection. Since B95a cells do not firmly adhere to plates, it is difficult to perform plaque titration accurately using them. Therefore, we determined TCID50 rather than PFU on B95a cells (6, 19).

Table 1 shows the titers obtained on the different types of cells when the same stock of the Edmonston or KA strain was used. The Edmonston strain produced comparable titers on all cell lines except for CHO cells, on which no plaques were produced. The B95a-isolated KA strain produced comparable titers on Vero/hSLAM, CHO/hSLAM, and B95a cells but produced no plaques on Vero, CHO, and CHO/CD46 cells, as expected from its tropism.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 1.   MV titers determined on different cell lines

We next determined the titers of viruses on throat swabs from nine patients with measles using Vero and Vero/hSLAM cells. CHO/CD46, CHO/SLAM, and B95a cells were also used for some patients. All of these patients had visited Kitakyushu Municipal Medical Center, Kitakyushu, Japan, in 2000 and were clinically diagnosed as having measles. Throat swabs were collected in 2 ml of phosphate-buffered saline within 3 days after the onset of rash and were stored at -80°C until the titrations were performed. The cells were inoculated with 0.2 ml of throat swabs from individual patients, and titrations were performed as described above. Table 1 shows the titers determined on the different samples. None of the samples produced any plaques on Vero cells. In contrast, samples from seven patients produced between 500 and 19,000 plaques per ml of inoculum on Vero/hSLAM cells (titrations were performed in duplicate). When CHO transfectants and B95a cells were used, the results were consistent with those obtained on Vero and Vero/hSLAM cells. Two samples neither produced any plaques on Vero/hSLAM cells nor caused any cytopathic effects in B95a cells. Considering that the Edmonston strain, which can use either CD46 or SLAM as a receptor, produced comparable titers on Vero and Vero/hSLAM cells or on CHO/CD46 and CHO/hSLAM cells, the proportion of the viruses which use CD46 as a receptor is at least 2 to 4 log units lower than the proportion of viruses which use SLAM only as a receptor.

This study indicated that the viruses in the bodies of measles patients, at least from a single outbreak, use SLAM but not CD46 as a receptor. This result is consistent with previous observations that with B95a cells, one can quickly and efficiently isolate MV from clinical specimens, whereas with Vero cells, the successful isolation rate is low and several blind passages are usually necessary (4, 6). On the other hand, a single amino acid substitution of the hemagglutinin at position 481 to tyrosine (1, 5, 7, 16, 21) or at position 546 to glycine (13, 16) may enable MV strains that use SLAM only as a receptor to interact with CD46. Viruses with such amino acid changes are easily generated during replication in measles patients, and once produced, they should be able to infect almost any cells in the body because CD46 is ubiquitously expressed (8). Although this study did not detect such viruses in the throat, they may exist in other organs or tissues, accounting for the pathogenesis of measles. In fact, Manchester et al. have reported that MV strains which were isolated by coculturing PBMCs of measles patients with human PBMCs and then propagated only in PBMCs use CD46 as a cellular receptor (9). However, we have demonstrated that even these PBMC-isolated strains, which did not efficiently replicate in CHO/CD46 cells (9), caused strong cytopathic effects in CHO/hSLAM cells (20), indicating that SLAM serves better as a receptor for these strains than CD46.

In view of our present results, we propose that the in vivo propagation of viruses that use CD46 as a receptor is suppressed by an unknown mechanism(s). Thus, the usage of CD46 as a receptor by the Edmonston and PBMC-isolated strains may be an in vitro adaptation rather than the in vivo property of the progenitors of those strains. At any rate, the viruses in the throat of a measles patient are transmitted to other susceptible people; therefore, viruses that use SLAM as a receptor are important in the pathogenesis and epidemiology of measles as they first enter the body and transmit the disease.


    ACKNOWLEDGMENTS

We thank F. Kobune and Y. Murakami for providing reagents and M. B. A. Oldstone for helpful discussions.

This work was supported by grants from the Ministry of Education, Science and Culture of Japan and from the Organization for Drug ADR Relief, R&D Promotion and Product Review of Japan.


    FOOTNOTES

* Corresponding author. Mailing address: Department of Virology, Faculty of Medicine, Kyushu University, Fukuoka 812-8582, Japan. Phone: 81-92-642-6135. Fax: 81-92-642-6140. E-mail: yyanagi{at}virology.med.kyushu-u.ac.jp.


    REFERENCES
Top
Abstract
Text
References

1. Bartz, R., U. Brinckmann, L. M. Dunster, B. Rima, V. ter Meulen, and J. Schneider-Schaulies. 1996. Mapping amino acids of the measles virus hemagglutinin responsible for receptor (CD46) downregulation. Virology 224:334-337[CrossRef][Medline].
2. Centers for Disease Control and Prevention. 1999. Global measles control and regional elimination, 1998-1999. Morb. Mortal. Wkly. Rep. 48:1124-1130[Medline].
3. Dorig, R. E., A. Marcil, A. Chopra, and C. D. Richardson. 1993. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75:295-305[CrossRef][Medline].
4. Griffin, D. E., and W. J. Bellini. 1996. Measles virus, p. 1267-1312. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Fields virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa.
5. Hsu, E. C., F. Sarangi, C. Iorio, M. S. Sidhu, S. A. Udem, D. L. Dillehay, W. Xu, P. A. Rota, W. J. Bellini, and C. D. Richardson. 1998. A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J. Virol. 72:2905-2916[Abstract/Free Full Text].
6. Kobune, F., H. Sakata, and A. Sugiura. 1990. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J. Virol. 64:700-705[Abstract/Free Full Text].
7. Lecouturier, V., J. Fayolle, M. Caballero, J. Carabana, M. L. Celma, R. Fernandez-Munoz, T. F. Wild, and R. Buckland. 1996. Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains. J. Virol. 70:4200-4204[Abstract].
8. Liszewski, K. M., T. W. Post, and J. P. Atkinson. 1991. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 9:431-455[CrossRef][Medline].
9. Manchester, M., D. S. Eto, A. Valsamakis, P. B. Liton, R. Fernandez-Munoz, P. A. Rota, W. J. Bellini, D. N. Forthal, and M. B. A. Oldstone. 2000. Clinical isolates of measles virus use CD46 as a cellular receptor. J. Virol. 74:3967-3974[Abstract/Free Full Text].
10. Naniche, D., G. Varior-Krishnan, F. Cervoni, T. F. Wild, B. Rossi, C. Rabourdin-Combe, and D. Gerlier. 1993. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67:6025-6032[Abstract/Free Full Text].
11. Niwa, H., K. Yamamura, and J. Miyazaki. 1991. Efficient selection for high-expression transfectants by a novel eukaryotic vector. Gene 108:193-200[CrossRef][Medline].
12. Ono, N., H. Tatsuo, K. Tanaka, H. Minagawa, and Y. Yanagi. 2001. V domain of human SLAM (CDw150) is essential for its function as a measles virus receptor. J. Virol. 75:1594-1600[Abstract/Free Full Text].
13. Rima, B. K., J. A. P. Earle, K. Baczko, V. ter Meulen, U. G. Liebert, C. Carstens, J. Carabana, M. Caballero, M. L. Celma, and R. Fernandez-Munoz. 1997. Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. J. Gen. Virol. 78:97-106[Abstract].
14. Schneider-Schaulies, J., L. M. Dunster, F. Kobune, B. Rima, and V. ter Meulen. 1995. Differential downregulation of CD46 by measles virus strains. J. Virol. 69:7257-7259[Abstract].
15. Schneider-Schaulies, J., J.-J. Schnorr, U. Brinckmann, L. M. Dunster, K. Baczko, U. G. Liebert, S. Schneider-Schaulies, and V. ter Meulen. 1995. Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains. Proc. Natl. Acad. Sci. USA 92:3943-3947[Abstract/Free Full Text].
16. Shibahara, K., H. Hotta, Y. Katayama, and M. Homma. 1994. Increased binding activity of measles virus to monkey red blood cells after long-term passage in Vero cell cultures. J. Gen. Virol. 75:3511-3516[Abstract/Free Full Text].
17. Sidorenko, S. P., and E. A. Clark. 1993. Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes. J. Immunol. 151:4614-4624[Abstract].
18. Tanaka, K., M. Xie, and Y. Yanagi. 1998. The hemagglutinin of recent measles virus isolates induces cell fusion in a marmoset cell line, but not in other CD46-positive human and monkey cell lines, when expressed together with the F protein. Arch. Virol. 143:213-225[CrossRef][Medline].
19. Tatsuo, H., K. Okuma, K. Tanaka, N. Ono, H. Minagawa, A. Takade, Y. Matsuura, and Y. Yanagi. 2000. Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins. J. Virol. 74:4139-4145[Abstract/Free Full Text].
20. Tatsuo, H., N. Ono, K. Tanaka, and Y. Yanagi. 2000. SLAM (CDw150) is a cellular receptor for measles virus. Nature 406:893-897[CrossRef][Medline].
21. Xie, M.-F., K. Tanaka, N. Ono, H. Minagawa, and Y. Yanagi. 1999. Amino acid substitutions at position 481 differently affect the ability of the measles virus hemagglutinin to induce cell fusion in monkey and marmoset cells co-expressing the fusion protein. Arch. Virol. 144:1689-1699[CrossRef][Medline].

Journal of Virology, May 2001, p. 4399-4401, Vol. 75, No. 9
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.9.4399-4401.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • de Swart, R. L., Yuksel, S., Langerijs, C. N., Muller, C. P., Osterhaus, A. D. M. E. (2009). Depletion of measles virus glycoprotein-specific antibodies from human sera reveals genotype-specific neutralizing antibodies. J. Gen. Virol. 90: 2982-2989 [Abstract] [Full Text]  
  • Paal, T., Brindley, M. A., St. Clair, C., Prussia, A., Gaus, D., Krumm, S. A., Snyder, J. P., Plemper, R. K. (2009). Probing the Spatial Organization of Measles Virus Fusion Complexes. J. Virol. 83: 10480-10493 [Abstract] [Full Text]  
  • Iwasaki, M., Takeda, M., Shirogane, Y., Nakatsu, Y., Nakamura, T., Yanagi, Y. (2009). The Matrix Protein of Measles Virus Regulates Viral RNA Synthesis and Assembly by Interacting with the Nucleocapsid Protein. J. Virol. 83: 10374-10383 [Abstract] [Full Text]  
  • Runkler, N., Dietzel, E., Carsillo, M., Niewiesk, S., Maisner, A. (2009). Sorting signals in the measles virus wild-type glycoproteins differently influence virus spread in polarized epithelia and lymphocytes. J. Gen. Virol. 90: 2474-2482 [Abstract] [Full Text]  
  • Yoon, J.-J., Krumm, S. A., Ndungu, J. M., Hoffman, V., Bankamp, B., Rota, P. A., Sun, A., Snyder, J. P., Plemper, R. K. (2009). Target Analysis of the Experimental Measles Therapeutic AS-136A. Antimicrob. Agents Chemother. 53: 3860-3870 [Abstract] [Full Text]  
  • Carsillo, M., Klapproth, K., Niewiesk, S. (2009). Cytokine Imbalance after Measles Virus Infection Has No Correlation with Immune Suppression. J. Virol. 83: 7244-7251 [Abstract] [Full Text]  
  • Akiyama, M., Kimura, H., Tsukagoshi, H., Taira, K., Mizuta, K., Saitoh, M., Nagano, M., Sutoh, A., Noda, M., Morita, Y., Sakatsume, O., Okabe, N., Tashiro, M. (2009). Development of an assay for the detection and quantification of the measles virus nucleoprotein (N) gene using real-time reverse transcriptase PCR. J Med Microbiol 58: 638-643 [Abstract] [Full Text]  
  • Takeda, M., Ohno, S., Tahara, M., Takeuchi, H., Shirogane, Y., Ohmura, H., Nakamura, T., Yanagi, Y. (2008). Measles Viruses Possessing the Polymerase Protein Genes of the Edmonston Vaccine Strain Exhibit Attenuated Gene Expression and Growth in Cultured Cells and SLAM Knock-In Mice. J. Virol. 82: 11979-11984 [Abstract] [Full Text]  
  • Dittmar, S., Harms, H., Runkler, N., Maisner, A., Kim, K. S., Schneider-Schaulies, J. (2008). Measles Virus-Induced Block of Transendothelial Migration of T Lymphocytes and Infection-Mediated Virus Spread across Endothelial Cell Barriers. J. Virol. 82: 11273-11282 [Abstract] [Full Text]  
  • Nakatsu, Y., Takeda, M., Ohno, S., Shirogane, Y., Iwasaki, M., Yanagi, Y. (2008). Measles Virus Circumvents the Host Interferon Response by Different Actions of the C and V Proteins. J. Virol. 82: 8296-8306 [Abstract] [Full Text]  
  • Yoon, J.-J., Chawla, D., Paal, T., Ndungu, M., Du, Y., Kurtkaya, S., Sun, A., Snyder, J. P., Plemper, R. K. (2008). High-Throughput Screening--Based Identification of Paramyxovirus Inhibitors. J Biomol Screen 13: 591-608 [Abstract]  
  • Lee, J. K., Prussia, A., Paal, T., White, L. K., Snyder, J. P., Plemper, R. K. (2008). Functional Interaction between Paramyxovirus Fusion and Attachment Proteins. J. Biol. Chem. 283: 16561-16572 [Abstract] [Full Text]  
  • Devaux, P., Hodge, G., McChesney, M. B., Cattaneo, R. (2008). Attenuation of V- or C-Defective Measles Viruses: Infection Control by the Inflammatory and Interferon Responses of Rhesus Monkeys. J. Virol. 82: 5359-5367 [Abstract] [Full Text]  
  • Tahara, M., Takeda, M., Shirogane, Y., Hashiguchi, T., Ohno, S., Yanagi, Y. (2008). Measles Virus Infects both Polarized Epithelial and Immune Cells by Using Distinctive Receptor-Binding Sites on Its Hemagglutinin. J. Virol. 82: 4630-4637 [Abstract] [Full Text]  
  • Navaratnarajah, C. K., Vongpunsawad, S., Oezguen, N., Stehle, T., Braun, W., Hashiguchi, T., Maenaka, K., Yanagi, Y., Cattaneo, R. (2008). Dynamic Interaction of the Measles Virus Hemagglutinin with Its Receptor Signaling Lymphocytic Activation Molecule (SLAM, CD150). J. Biol. Chem. 283: 11763-11771 [Abstract] [Full Text]  
  • Pan, C.-H., Nair, N., Adams, R. J., Zink, M. C., Lee, E.-Y., Polack, F. P., Singh, M., O'Hagan, D. T., Griffin, D. E. (2008). Dose-Dependent Protection against or Exacerbation of Disease by a Polylactide Glycolide Microparticle-Adsorbed, Alphavirus-Based Measles Virus DNA Vaccine in Rhesus Macaques. CVI 15: 697-706 [Abstract] [Full Text]  
  • Bitsko, R. H., Cortese, M. M., Dayan, G. H., Rota, P. A., Lowe, L., Iversen, S. C., Bellini, W. J. (2008). Detection of RNA of Mumps Virus during an Outbreak in a Population with a High Level of Measles, Mumps, and Rubella Vaccine Coverage. J. Clin. Microbiol. 46: 1101-1103 [Abstract] [Full Text]  
  • Ungerechts, G., Springfeld, C., Frenzke, M. E., Lampe, J., Johnston, P. B., Parker, W. B., Sorscher, E. J., Cattaneo, R. (2007). Lymphoma Chemovirotherapy: CD20-Targeted and Convertase-Armed Measles Virus Can Synergize with Fludarabine. Cancer Res. 67: 10939-10947 [Abstract] [Full Text]  
  • Takeda, M., Tahara, M., Hashiguchi, T., Sato, T. A., Jinnouchi, F., Ueki, S., Ohno, S., Yanagi, Y. (2007). A Human Lung Carcinoma Cell Line Supports Efficient Measles Virus Growth and Syncytium Formation via a SLAM- and CD46-Independent Mechanism. J. Virol. 81: 12091-12096 [Abstract] [Full Text]  
  • Shingai, M., Ebihara, T., Begum, N. A., Kato, A., Honma, T., Matsumoto, K., Saito, H., Ogura, H., Matsumoto, M., Seya, T. (2007). Differential Type I IFN-Inducing Abilities of Wild-Type versus Vaccine Strains of Measles Virus. J. Immunol. 179: 6123-6133 [Abstract] [Full Text]  
  • del Valle, J. R., Devaux, P., Hodge, G., Wegner, N. J., McChesney, M. B., Cattaneo, R. (2007). A Vectored Measles Virus Induces Hepatitis B Surface Antigen Antibodies While Protecting Macaques against Measles Virus Challenge. J. Virol. 81: 10597-10605 [Abstract] [Full Text]  
  • Corey, E. A., Iorio, R. M. (2007). Mutations in the Stalk of the Measles Virus Hemagglutinin Protein Decrease Fusion but Do Not Interfere with Virus-Specific Interaction with the Homologous Fusion Protein. J. Virol. 81: 9900-9910 [Abstract] [Full Text]  
  • Tahara, M., Takeda, M., Yanagi, Y. (2007). Altered Interaction of the Matrix Protein with the Cytoplasmic Tail of Hemagglutinin Modulates Measles Virus Growth by Affecting Virus Assembly and Cell-Cell Fusion. J. Virol. 81: 6827-6836 [Abstract] [Full Text]  
  • Tahara, M., Takeda, M., Seki, F., Hashiguchi, T., Yanagi, Y. (2007). Multiple Amino Acid Substitutions in Hemagglutinin Are Necessary for Wild-Type Measles Virus To Acquire the Ability To Use Receptor CD46 Efficiently. J. Virol. 81: 2564-2572 [Abstract] [Full Text]  
  • Ohno, S., Ono, N., Seki, F., Takeda, M., Kura, S., Tsuzuki, T., Yanagi, Y. (2007). Measles Virus Infection of SLAM (CD150) Knockin Mice Reproduces Tropism and Immunosuppression in Human Infection. J. Virol. 81: 1650-1659 [Abstract] [Full Text]  
  • Nakatsu, Y., Takeda, M., Ohno, S., Koga, R., Yanagi, Y. (2006). Translational Inhibition and Increased Interferon Induction in Cells Infected with C Protein-Deficient Measles Virus. J. Virol. 80: 11861-11867 [Abstract] [Full Text]  
  • Yanagi, Y., Takeda, M., Ohno, S. (2006). Measles virus: cellular receptors, tropism and pathogenesis.. J. Gen. Virol. 87: 2767-2779 [Abstract] [Full Text]  
  • Schneider-Schaulies, S., Dittmer, U. (2006). Silencing T cells or T-cell silencing: concepts in virus-induced immunosuppression. J. Gen. Virol. 87: 1423-1438 [Abstract] [Full Text]  
  • Seki, F., Takeda, M., Minagawa, H., Yanagi, Y. (2006). Recombinant wild-type measles virus containing a single N481Y substitution in its haemagglutinin cannot use receptor CD46 as efficiently as that having the haemagglutinin of the Edmonston laboratory strain. J. Gen. Virol. 87: 1643-1648 [Abstract] [Full Text]  
  • Takeda, M., Nakatsu, Y., Ohno, S., Seki, F., Tahara, M., Hashiguchi, T., Yanagi, Y. (2006). Generation of Measles Virus with a Segmented RNA Genome. J. Virol. 80: 4242-4248 [Abstract] [Full Text]  
  • Tahara, M., Takeda, M., Yanagi, Y. (2005). Contributions of Matrix and Large Protein Genes of the Measles Virus Edmonston Strain to Growth in Cultured Cells as Revealed by Recombinant Viruses. J. Virol. 79: 15218-15225 [Abstract] [Full Text]  
  • Takeda, M., Ohno, S., Seki, F., Nakatsu, Y., Tahara, M., Yanagi, Y. (2005). Long Untranslated Regions of the Measles Virus M and F Genes Control Virus Replication and Cytopathogenicity. J. Virol. 79: 14346-14354 [Abstract] [Full Text]  
  • Heinzerling, L., Kunzi, V., Oberholzer, P. A., Kundig, T., Naim, H., Dummer, R. (2005). Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells. Blood 106: 2287-2294 [Abstract] [Full Text]  
  • Obojes, K., Andres, O., Kim, K. S., Daubener, W., Schneider-Schaulies, J. (2005). Indoleamine 2,3-Dioxygenase Mediates Cell Type-Specific Anti-Measles Virus Activity of Gamma Interferon. J. Virol. 79: 7768-7776 [Abstract] [Full Text]  
  • Takeuchi, K., Takeda, M., Miyajima, N., Ami, Y., Nagata, N., Suzaki, Y., Shahnewaz, J., Kadota, S.-i., Nagata, K. (2005). Stringent Requirement for the C Protein of Wild-Type Measles Virus for Growth both In Vitro and in Macaques. J. Virol. 79: 7838-7844 [Abstract] [Full Text]  
  • Kitagawa, Y., Tani, H., Limn, C. K., Matsunaga, T. M., Moriishi, K., Matsuura, Y. (2005). Ligand-Directed Gene Targeting to Mammalian Cells by Pseudotype Baculoviruses. J. Virol. 79: 3639-3652 [Abstract] [Full Text]  
  • Ohno, S., Ono, N., Takeda, M., Takeuchi, K., Yanagi, Y. (2004). Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction. J. Gen. Virol. 85: 2991-2999 [Abstract] [Full Text]  
  • Vongpunsawad, S., Oezgun, N., Braun, W., Cattaneo, R. (2004). Selectively Receptor-Blind Measles Viruses: Identification of Residues Necessary for SLAM- or CD46-Induced Fusion and Their Localization on a New Hemagglutinin Structural Model. J. Virol. 78: 302-313 [Abstract] [Full Text]  
  • Seki, F., Ono, N., Yamaguchi, R., Yanagi, Y. (2003). Efficient Isolation of Wild Strains of Canine Distemper Virus in Vero Cells Expressing Canine SLAM (CD150) and Their Adaptability to Marmoset B95a Cells. J. Virol. 77: 9943-9950 [Abstract] [Full Text]  
  • Ohno, S., Seki, F., Ono, N., Yanagi, Y. (2003). Histidine at position 61 and its adjacent amino acid residues are critical for the ability of SLAM (CD150) to act as a cellular receptor for measles virus. J. Gen. Virol. 84: 2381-2388 [Abstract] [Full Text]  
  • Shingai, M., Ayata, M., Ishida, H., Matsunaga, I., Katayama, Y., Seya, T., Tatsuo, H., Yanagi, Y., Ogura, H. (2003). Receptor use by vesicular stomatitis virus pseudotypes with glycoproteins of defective variants of measles virus isolated from brains of patients with subacute sclerosing panencephalitis. J. Gen. Virol. 84: 2133-2143 [Abstract] [Full Text]  
  • Andres, O., Obojes, K., Kim, K. S., Meulen, V. t., Schneider-Schaulies, J. (2003). CD46- and CD150-independent endothelial cell infection with wild-type measles viruses. J. Gen. Virol. 84: 1189-1197 [Abstract] [Full Text]  
  • Hahm, B., Arbour, N., Naniche, D., Homann, D., Manchester, M., Oldstone, M. B. A. (2003). Measles Virus Infects and Suppresses Proliferation of T Lymphocytes from Transgenic Mice Bearing Human Signaling Lymphocytic Activation Molecule. J. Virol. 77: 3505-3515 [Abstract] [Full Text]  
  • Pfeuffer, J., Puschel, K., Meulen, V. t., Schneider-Schaulies, J., Niewiesk, S. (2002). Extent of Measles Virus Spread and Immune Suppression Differentiates between Wild-Type and Vaccine Strains in the Cotton Rat Model (Sigmodon hispidus). J. Virol. 77: 150-158 [Abstract] [Full Text]  
  • Howie, D., Okamoto, S., Rietdijk, S., Clarke, K., Wang, N., Gullo, C., Bruggeman, J. P., Manning, S., Coyle, A. J., Greenfield, E., Kuchroo, V., Terhorst, C. (2002). The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon gamma production. Blood 100: 2899-2907 [Abstract] [Full Text]  
  • Bieback, K., Lien, E., Klagge, I. M., Avota, E., Schneider-Schaulies, J., Duprex, W. P., Wagner, H., Kirschning, C. J., ter Meulen, V., Schneider-Schaulies, S. (2002). Hemagglutinin Protein of Wild-Type Measles Virus Activates Toll-Like Receptor 2 Signaling. J. Virol. 76: 8729-8736 [Abstract] [Full Text]  
  • Schneider, U., von Messling, V., Devaux, P., Cattaneo, R. (2002). Efficiency of Measles Virus Entry and Dissemination through Different Receptors. J. Virol. 76: 7460-7467 [Abstract] [Full Text]  
  • Hashimoto, K., Ono, N., Tatsuo, H., Minagawa, H., Takeda, M., Takeuchi, K., Yanagi, Y. (2002). SLAM (CD150)-Independent Measles Virus Entry as Revealed by Recombinant Virus Expressing Green Fluorescent Protein. J. Virol. 76: 6743-6749 [Abstract] [Full Text]  
  • Erlenhofer, C., Duprex, W. P., Rima, B. K., ter Meulen, V., Schneider-Schaulies, J. (2002). Analysis of receptor (CD46, CD150) usage by measles virus. J. Gen. Virol. 83: 1431-1436 [Abstract] [Full Text]  
  • Christiansen, D., De Sousa, E. R., Loveland, B., Kyriakou, P., Lanteri, M., Wild, F. T., Gerlier, D. (2002). A CD46CD[55-46] chimeric receptor, eight short consensus repeats long, acts as an inhibitor of both CD46 (MCP)- and CD150 (SLAM)-mediated cell-cell fusion induced by CD46-using measles virus. J. Gen. Virol. 83: 1147-1155 [Abstract] [Full Text]  
  • Takeuchi, K., Takeda, M., Miyajima, N., Kobune, F., Tanabayashi, K., Tashiro, M. (2002). Recombinant Wild-Type and Edmonston Strain Measles Viruses Bearing Heterologous H Proteins: Role of H Protein in Cell Fusion and Host Cell Specificity. J. Virol. 76: 4891-4900 [Abstract] [Full Text]  
  • Waku Kouomou, D., Wild, T. F. (2002). Adaptation of Wild-Type Measles Virus to Tissue Culture. J. Virol. 76: 1505-1509 [Abstract] [Full Text]  
  • Howie, D., Simarro, M., Sayos, J., Guirado, M., Sancho, J., Terhorst, C. (2002). Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation. Blood 99: 957-965 [Abstract] [Full Text]  
  • Minagawa, H., Tanaka, K., Ono, N., Tatsuo, H., Yanagi, Y. (2001). Induction of the measles virus receptor SLAM (CD150) on monocytes. J. Gen. Virol. 82: 2913-2917 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ono, N.
Right arrow Articles by Yanagi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ono, N.
Right arrow Articles by Yanagi, Y.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»